General Description
Amodiaquine Hydrochloride 176.32mg equivalent to Amodiaquine 135mg base
+ Artesunate 50mg fixed dose combination, bilayered tablets, blister of
3/PAC-25
Technical specifications
Each fixed dose combination bilayered tablet contains Amodiaquine
Hydrochloride 176.32mg, equivalent to Amodiaquine base 135mg +
Artesunate 50mg.
The tablet should be scored with at least one break line to allow for
division of tablets into two parts, each containing the same amount of
active ingredients.
Therapeutic class
Amodiaquine is a 4-Aminoquinolone
Artesunate is an Artemesinin derivative
Standard shelf life
2 years (24 months)
Other available formulations
AQ 153mg & AS 50mg Co-blister 3+3, 6+6
AQ 75mg & AS 25mg Co-blister 6+6 ? NA from UNICEF
AQ 150mg & AS 50mg Co-blister 3+3, 6+6
AQ 153mg+AS 50mg Fixed dose combination bilayered tablets, 3s, 6s, 12s -
NA from UNICEF
AQ 67.5mg+AS 25mg Fixed dose combination bilayered tablets, 3s
AQ 135mg+AS 50mg Fixed dose combination bilayered tablets, 3s
AQ 270mg+AS 100mg Fixed dose combination bilayered tablets, 3s, 6s
AQ 306.2mg+ AS 100mg Fixed dose combination tablets 3s, 6s - NA from
UNICEF
Storage
Do not store above 30 °C (86 °F).
Keep out of the reach and sight of children.
Dispensing instructions
Dispense in original container. Do not repack.
Tablets may be broken or crushed as needed.
Guidelines for use
For more details, please see
World Health Organisation (WHO), Guidelines for the treatment of
Malaria: (www.who.int/malaria/en/)
WHO, Model Lists of Essential Medicines for adults and/or children
respectively:
(www.who.int/medicines/publications/essentialmedicines/en/index.html)
WHO Model Formulary: (apps.who.int/emlib/Default.aspx?Language=EN)
or your regional and/or national guidelines.
to top
|